摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2-(3-methoxy-4-nitrophenyl)-2-oxoethyl]pyridinium bromide

中文名称
——
中文别名
——
英文名称
1-[2-(3-methoxy-4-nitrophenyl)-2-oxoethyl]pyridinium bromide
英文别名
1-[2-(3-Methoxy-4-nitrophenyl)-2-oxoethyl]pyridinium bromide;1-(3-methoxy-4-nitrophenyl)-2-pyridin-1-ium-1-ylethanone;bromide
1-[2-(3-methoxy-4-nitrophenyl)-2-oxoethyl]pyridinium bromide化学式
CAS
——
化学式
Br*C14H13N2O4
mdl
——
分子量
353.172
InChiKey
ZIDJOHOGJHKUNG-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.22
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    76
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    1-[2-(3-methoxy-4-nitrophenyl)-2-oxoethyl]pyridinium bromide4,4,4-三氟-2-丁酸乙酯 在 tetrapyridinecobalt(II) dichromate 、 三乙胺 作用下, 以 DMF (N,N-dimethyl-formamide) 为溶剂, 反应 6.0h, 以71%的产率得到ethyl [3-(3-methoxy-4-nitrobenzoyl)-2-(trifluoromethyl)indolizin-1-yl]carboxylate
    参考文献:
    名称:
    Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
    摘要:
    化学式I或其盐的化合物:其中R1代表—OH,(C1-C5)烷氧基,羧基,(C2-C6)烷氧羰基,—NR5R6,—NH—SO2-Alk,—NH—SO2-Ph,—NH—CO-Ph,—N(Alk)-CO-Ph,—NH—CO—NH-Ph,—NH—CO-Alk,—NH—CO2-Alk,—O—(CH2)n-烷基,—O-Alk-COOR7,—O-Alk-O—R8,—O-Alk-OH,—O-Alk-C(NH2):NOH,—O-Alk-NR5R6,—O-Alk-CN,—O—(CH2)n-Ph,—O-Alk-CO—NR5R6,—CO—NH—(CH2)m—COOR7,—CO—NH-AlkR2代表H,(C1-C5)烷基,(C1-C5)烷基卤化物,(C3-C6)环烷基或苯基,可选择性地取代,A代表—CO—,—SO—或—SO2—,R3和R4相同或不同,各自代表H,(C1-C5)烷氧基,氨基,羧基,(C2-C6)烷氧羰基,—OH,硝基,羟胺基,-Alk-COOR7,—NR5R6,—NH-Alk-COOR7,—NH—COO-Alk,—N(R11)—SO2-Alk-NR9R10,—N(R11)—SO2-Alk,—N(R11)-Alk-NR5R6,—N(R11)—CO-Alk-NR9R10,—N(R11)—CO-Alk,—N(R11)—CO—CF3,—NH-Alk-HetN,—O-Alk-NR9R10,—O-Alk-CO—NR5R6,—O-Alk-HetN,或R3和R4共同形成5-至6-成员不饱和杂环,是基本成纤维细胞生长因子的抑制剂。
    公开号:
    US20050203126A1
  • 作为产物:
    描述:
    吡啶2-溴-1-(3-甲氧基-4-硝基苯基)-1-乙酮乙腈 为溶剂, 反应 5.0h, 以97%的产率得到1-[2-(3-methoxy-4-nitrophenyl)-2-oxoethyl]pyridinium bromide
    参考文献:
    名称:
    Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
    摘要:
    化学式I或其盐的化合物:其中R1代表—OH,(C1-C5)烷氧基,羧基,(C2-C6)烷氧羰基,—NR5R6,—NH—SO2-Alk,—NH—SO2-Ph,—NH—CO-Ph,—N(Alk)-CO-Ph,—NH—CO—NH-Ph,—NH—CO-Alk,—NH—CO2-Alk,—O—(CH2)n-烷基,—O-Alk-COOR7,—O-Alk-O—R8,—O-Alk-OH,—O-Alk-C(NH2):NOH,—O-Alk-NR5R6,—O-Alk-CN,—O—(CH2)n-Ph,—O-Alk-CO—NR5R6,—CO—NH—(CH2)m—COOR7,—CO—NH-AlkR2代表H,(C1-C5)烷基,(C1-C5)烷基卤化物,(C3-C6)环烷基或苯基,可选择性地取代,A代表—CO—,—SO—或—SO2—,R3和R4相同或不同,各自代表H,(C1-C5)烷氧基,氨基,羧基,(C2-C6)烷氧羰基,—OH,硝基,羟胺基,-Alk-COOR7,—NR5R6,—NH-Alk-COOR7,—NH—COO-Alk,—N(R11)—SO2-Alk-NR9R10,—N(R11)—SO2-Alk,—N(R11)-Alk-NR5R6,—N(R11)—CO-Alk-NR9R10,—N(R11)—CO-Alk,—N(R11)—CO—CF3,—NH-Alk-HetN,—O-Alk-NR9R10,—O-Alk-CO—NR5R6,—O-Alk-HetN,或R3和R4共同形成5-至6-成员不饱和杂环,是基本成纤维细胞生长因子的抑制剂。
    公开号:
    US20050203126A1
点击查看最新优质反应信息

文献信息

  • Novel 1,2,3-Substituted Indolizine Derivatives, Inhibitors of FGFs, Method for Preparing Them and Pharmaceutical Compositions Containing Them
    申请人:BADORC Alain
    公开号:US20090023770A1
    公开(公告)日:2009-01-22
    The present invention relates to novel 1,2,3-substituted indolizine derivative which are inhibitors of fibroblast growth factors, to methods or preparing such derivatives, to pharmaceutical compositions comprising such derivatives, and to methods of treatment comprising such derivatives.
    本发明涉及新型1,2,3-取代吲哚嗪衍生物,它们是成纤维细胞生长因子的抑制剂,涉及制备这种衍生物的方法,涉及包含这种衍生物的制药组合物,以及涉及使用这种衍生物的治疗方法。
  • 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
    申请人:Sanofi-Aventis
    公开号:US07442708B2
    公开(公告)日:2008-10-28
    Compounds of formula I or salts thereof: in which R1 represents —OH, (C1-C5)alkoxy, carboxyl, (C2-C6)alkoxycarbonyl, —NR5R6, —NH—SO2-Alk, —NH—SO2-Ph, —NH—CO-Ph, —N(Alk)-CO-Ph, —NH—CO—NH-Ph, —NH—CO-Alk, —NH—CO2-Alk, —O—(CH2)n-cAlk, —O-Alk-COOR7, —O-Alk-O—R8, —O-Alk-OH, —O-Alk-C(NH2):NOH, —O-Alk-NR5R6, —O-Alk-CN, —O—(CH2)n-Ph, —O-Alk-CO—NR5R6, —CO—NH—(CH2)m—COOR7, —CO—NH-Alk R2 represents H, (C1-C5)alkyl, (C1-C5)alkyl halide, (C3-C6)cycloalkyl or phenyl which is optionally substituted, A represents —CO—, —SO— or —SO2—, R3 and R4 which are identical or different, each represent H, (C1-C5)alkoxy, amino, carboxyl, (C2-C6)alkoxycarbonyl, —OH, nitro, hydroxyamino, -Alk-COOR7, —NR5R6, —NH-Alk-COOR7, —NH—COO-Alk, —N(R11)—SO2-Alk-NR9R10, —N(R11)—SO2-Alk, —N(R11)-Alk-NR5R6, —N(R11)—CO-Alk-NR9R10, —N(R11)—CO-Alk, —N(R11)—CO—CF3, —NH-Alk-HetN, —O-Alk-NR9R10, —O-Alk-CO—NR5R6, —O-Alk-HetN, or R3 and R4 form together a 5- to 6-membered unsaturated heterocycle, are inhibitors of basic fibroblast growth factors.
    化合物I的公式或其盐: 其中 R1代表-OH,(C1-C5)烷氧基,羧基,(C2-C6)烷氧羰基,-NR5R6,-NH-SO2-Alk,-NH-SO2-Ph,-NH-CO-Ph,-N(Alk)-CO-Ph,-NH-CO-NH-Ph,-NH-CO-Alk,-NH-CO2-Alk,-O-(CH2)n-烷基,-O-Alk-COOR7,-O-Alk-O-R8,-O-Alk-OH,-O-Alk-C(NH2):NOH,-O-Alk-NR5R6,-O-Alk-CN,-O-(CH2)n-Ph,-O-Alk-CO-NR5R6,-CO-NH-(CH2)m-COOR7,-CO-NH-Alk R2代表H,(C1-C5)烷基,(C1-C5)烷基卤代,(C3-C6)环烷基或苯基,可选地取代 A代表-CO-,-SO-或-SO2- R3和R4相同或不同,每个代表H,(C1-C5)烷氧基,氨基,羧基,(C2-C6)烷氧羰基,-OH,硝基,羟基氨基,-Alk-COOR7,-NR5R6,-NH-Alk-COOR7,-NH-COO-Alk,-N(R11)-SO2-Alk-NR9R10,-N(R11)-SO2-Alk,-N(R11)-Alk-NR5R6,-N(R11)-CO-Alk-NR9R10,-N(R11)-CO-Alk,-N(R11)-CO-CF3,-NH-Alk-HetN,-O-Alk-NR9R10,-O-Alk-CO-NR5R6,-O-Alk-HetN,或R3和R4一起形成5-至6-成员的不饱和杂环,是基本成纤维细胞生长因子的抑制剂。
  • 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for preparing them and pharmaceutical compositions containing them
    申请人:Sanofi-Aventis
    公开号:US07803811B2
    公开(公告)日:2010-09-28
    The present invention relates to novel 1,2,3-substituted indolizine derivative which are inhibitors of fibroblast growth factors, to methods or preparing such derivatives, to pharmaceutical compositions comprising such derivatives, and to methods of treatment comprising such derivatives.
    本发明涉及一种新型的1,2,3-取代吲哚嗪衍生物,其为成纤维细胞生长因子的抑制剂,以及制备这种衍生物的方法,包括含有这种衍生物的制药组合物,以及包括这种衍生物的治疗方法。
  • US7442708B2
    申请人:——
    公开号:US7442708B2
    公开(公告)日:2008-10-28
  • US7803811B2
    申请人:——
    公开号:US7803811B2
    公开(公告)日:2010-09-28
查看更多